CDI Researcher's Work Earns $1 Million Funding from Hyundai
Dr. Druley, a Washington University School of Medicine associate professor of pediatrics and a St. Louis Children's Hospital oncologist, aims to improve outcomes in children with AML. This cancer of the bone marrow results in 50% of pediatric cancer deaths. One reason for poor outcomes is the inability to precisely judge genetic differences in the disease both before and after treatment. This HHOW Quantum Award will leverage a multi-disciplinary team of pediatric leukemia experts to study very rare AML mutations in order to tailor therapies to the unique biology of children—improving treatments and increasing survival rates.
To read more about Dr. Druley and HHOW, click here.